A Swiss multicentric project to Improve the prevention of cardiovascular event recurrence after acute coronary syndromes;Un projet multicentrique suisse pour améliorer la prévention et la récidive après un syndrome coronarien aigu

Revue Medicale Suisse

Volumn 6, Issue 239, 2010, Pages 518-524

  Carballo, David ^a   Auer, Reto ^d   Carballo, Sebastian ^b   Windecker, Stefan ^e   Matter, Christian ^f   Luscher, Thomas ^f   Vogt, Pierre ^d   Perneger, Thomas ^c   Mach, François ^a   Rodondi, Nicolas ^d   Keller, Pierre Frédéric ^a   Raeber, Lorenz ^e   Jüni, Peter ^e   Klingenberg, Roland ^f   Altweg, Lukas ^f   Templin, Christian ^f   Landmesser, Ulf ^f   Maier, Willibald ^f   Scherrer, Florence ^g   Golay, Alain ^g   Gache, Pascal ^h   Sommer, Johanna ^h   Reffet, Agnès ⁱ   Schneider, Franck ⁱ   Richard Ariaud, Ariel ⁱ   Hugli, Olivier ^j   Waeber, Gérard ^k   Comuz, Jacques ^l   more..

^a Service de Cardiologie   (Switzerland)

^b SERVICE DE MÉDECINE INTERNE GÉNÉRALE   (Switzerland)

^c HUG   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^g Service d'Enseignement Thérapeutique des Maladies Chroniques   (Switzerland)

^h Service de Médecine Communautaire   (Switzerland)

ⁱ Service de la Communication Multi médias   (Switzerland)

^j Service des Urgences   (Switzerland)

^k Réseau Hospitalier du Valais   (Switzerland)

^l NONE   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY STENT; HUMAN; MORTALITY; RECURRENT DISEASE; STEM CELL;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HOSPITALIZATION; HUMANS; PROGNOSIS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 77950135706     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Observatoire suisse de la santé. Rapport annuel 2008. Neuchâtel: Office fédéral de la statistique; 2009.
2. Office fédéral de la statistique Mortalité, causes de décès en 2007 - Données, indicateurs.
3. Steg PG, Bhatt DL, Wilson PWF, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297:1197-206.
4. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-504.
5. * Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006;166:1842-7.
6. Butler J, Arbogast PG, BeLue R, et al. Outpatient adherence to beta-blocker therapy after acute myocardial infarction. J Am Coll Cardiol 2002;40:1589-95.
7. Smith CS, Cannon CP, McCabe CH, et al. Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: Observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial. Am Heart J 2005;149:444-50.
8. Rigotti NA, Singer DE, Mulley AG, Thibault GE. Smoking cessation following admission to a coronary care unit. J Gen Intern Med 1991;6:305-11.
9. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: The case of smoking cessation. Health Educ Res 2003;18:156-70.
10. Fox KA, Goodman SG, Klein W, et al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002;23:1177-89.
11. * Fonarow GC, Gawlinski A, Moughrabi S, Tillisch JH. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 2001;87:819-21
12. * Lappe JM, Muhlestein JB, Lappe DL, et al. Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program. Ann Intern Med 2004;141:446-53.
13. Eagle KA, Montoye CK, Riba AL, et al. Guideline-based standardized care is associated with substantially lower mortality in medicare patients with acute myocardial infarction: The American College of Cardiology's Guidelines Applied in Practice (GAP) projects in Michigan. J Am Coll Cardiol 2005;46:1242-8.
14. Wood DA, Kotseva K, Connolly S, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: A paired, cluster-randomised controlled trial. Lancet 2008;371:1999-2012.
15. ** Auer R, Gaume J, Rodondi N, Cornuz J, Ghali WA. Efficacy of in-hospttal multidimensional interventions of secondary prevention after acute coronary syndrome: A systematic review and meta-analysis. Circulation 2008;117:3109-17.
16. Ockene IS, Hayman LL, Pasternak RC, Schron E, Dunbar-Jacob J. Task Force #4 - adherence issues and behavior changes: Achieving a long-term solution. J Am Coll Cardiol 2002;40:630-40.
17. Keller PF, Barthassat V, Scherrer-Burri F, Lagger G, Carballo S. Fighting heart attacks and atherosclerosis: A therapeutical challenge. Rev Med Suisse 2008;4:1345-6, 1348-9.
18. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
19. Weber M, Bazzino O, Navarro Estrada JL, et al. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. J Am Coll Cardiol 2008;51:1188-95.
20. Verma S, Szmitko PE, Ridker PM. C-reactive protein comes of age. Nat Clin Pratt Cardiovasc Med 2005;2:29-36; quiz 58.
21. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-660.